Abstract:Yinci Zhu, 1, 2 Zhong Zheng, 1, 2 Bihong Fan, 1, 2 Yun Sun, 1, 2 Junyu Zhai, 1, 2 Yanzhi Du 1, 2 1 Department of Reproductive Medicine, Ren Ji Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai, 200135, People's Republic of China; 2 Shanghai Key Laboratory for Assisted Reproduction and Reproductive Genetics, Shanghai, 200135, People's Republic of China Correspondence: Junyu Zhai; Yanzhi Du, Department of Reproductive Medicine, Ren Ji Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai, 200135, People's Republic of China, Tel +86-21-20284525; +86-21-20284518, Email ; Purpose: Together with ultrasound measurement of follicle size, serum estradiol (E 2 ) provides guidance for controlled ovarian hyperstimulation (COH). However, during the COH process, some patients experience decreased serum E 2 level, especially before human chorionic gonadotropin (hCG) trigger. In order to elucidate the effect of E 2 reduction as well as the role of oral contraceptive pretreatment, a retrospective study was performed in our center from 2013 to 2019. Patients and Methods: In total, 333 patients who experienced an E 2 decrease prior to hCG administration were recruited as E 2 decline group, while 333 patients with continuously E 2 increase during COH were considered as control group. Based on pretreatment strategy, the two groups were further categorized into oral contraceptive (OC) and non-OC sub-groups, and IVF and clinical outcomes were compared between paired groups. Results: Number of dominant follicles on hCG day and normally fertilized zygotes were significantly decreased in E 2 decline group, and the significantly reduced live birth rate in E 2 decline group indicated the close relationship between E 2 decline and clinical outcomes. To analyse further, we found that in patients without OC pretreatment, the pregnancy rate and live birth rate of E 2 decline group (n = 141) were significantly lower than control group (n = 136) (56.3% versus 68.0%, 50.8% versus 63.5%, respectively). However, for patients with OC pretreatment, no difference was detected between two groups, suggesting a potential effect of OC pretreatment on clinical outcomes. Conclusion: E 2 decline prior to hCG-triggering day adversely affects IVF and clinical outcomes in patients without OC pretreatment, especially fertilization rate and live birth rate. Keywords: estradiol decline, controlled ovarian hyperstimulation, oral contraceptive, in vitro fertilization, fertilization rate, live birth rate Serum estradiol (E 2 ) measurement is recognized as an indispensable parameter for follicle monitoring during controlled ovarian hyperstimulation (COH) in in vitro fertilization (IVF) cycles. 1,2 The E 2 value of different stages can be indicative for assessment and prognosis of treatment protocols when combined with other index. 3,4 Moreover, high level of serum E 2 associated with multiple follicle development in high responders may predict high risk for ovarian hyperstimulation syndrome (OHSS). 5,6 Prior to the prevalence of GnRH agonist protocols, decreased serum E 2 level before the day of human chorionic gonadotropin (hCG) administration was related to suboptimal IVF indexes even clinical outcomes. 7 Subsequently, several studies focused on the effects of serum E 2 decline in GnRH agonist protocols. A.K. Styer et al reported that decreased E 2 level before the day of hCG administration had no impact on pregnancy loss rate or live birth rate of the patients with GnRH-agonist protocol. 8 On the other side, S. Fisher et al concluded that in either standard long or flare protocol, spontaneously falling E 2 was linked to lower fertilization rate and clinical pregnancy rate compared to controls, whereas no such differences existed in patients with decreased E 2 due to deliberate protocol modification. 9 Thus, monitoring of E 2 level is closely related to drug adjustment during COH. In flare and antagonist protocols, oral contraceptive (OC) is frequently used as a pretreatment strategy before COH. Therefore, we focused on the role of E 2 drop before hCG-triggering and its relationship to OC pretreatment. Previous summary and conclusion were based mainly on two protocols and limited sample size, making the conclusion ambiguous. In order to clarify the above issues, we selected patients from a broader scale with different treatment protocols, -Abstract Truncated-

Effects of oral contraceptives on ovulation induction in in vitro fertilization patients with premature ovarian insufficiency

The effect of progesterone level prior to oocyte retrieval on the numbers of oocytes retrieved and embryo quality in IVF treatment cycles: an analysis of 2,978 cycles

The Activation of Residual Dormant Follicles by Human Chorionic Gonadotropin (HCG) in Vivo: a Novel Treatment for Premature Ovarian Insufficiency

Successive and Cyclic Oral Contraceptive Pill Pretreatment Improves IVF/ICSI Outcomes of PCOS Patients and Ameliorates Hyperandrogenism and Antral Follicle Excess.

Effect of Pretreatment with Oral Contraceptives and Progestins on IVF Outcomes in Women with Polycystic Ovary Syndrome

[Effect of Oral Contraceptive Pills Upon IVF Outcomes of Patients under a Short GnRH Agonist Protocol].

The effect of oral contraceptive pill and luteal phase estradiol pretreatment on the patients with poor ovarian response

Effects of herbal medicine on ovulation in premature ovarian insufficiency patients during in vitro fertilization

The decision for GnRH antagonist protocol in PCOS patients:with or without oral contraceptive pill ;pretreatment Y

Effect of Oral Contraceptive Pill Pre-treatment before GnRH Antagonist Protocol in PCOS Patients Undergoing Controlled Hyperstimulation

Effect of pretreatment oral contraceptives on fresh and cumulative live birth in vitro fertilization outcomes in ovulatory women

Estrogen treatment in infertile women with premature ovarian insufficiency in transitional phase: a retrospective analysis

The Pregnancy Outcomes of Infertile Women with Polycystic Ovary Syndrome Undergoing Intrauterine Insemination with Different Attempts of Previous Ovulation Induction.

First intention IVF protocol for polycystic ovaries: does oral contraceptive pill pretreatment influence COH outcome?

Comparison of Three Ovulation Induction Therapies for Patients With Polycystic Ovary Syndrome and Infertility

Estradiol Decline Before hCG Administration in COH Has a Negative Effect on IVF Outcomes in Patients Without OC Pretreatment

Live births from in vitro fertilization-embryo transfer following the administration of gonadotropin-releasing hormone agonist without gonadotropins: Two case reports

Optimal Candidates to Do Fresh Embryo Transfer in Those Using Oral Contraceptive Pretreatment in IVF Cycles

Study of predictive indicators and pregnancy outcome of poor ovarian response in controlled ovarian hyper-stimulation

Does progesterone-induced endometrial withdrawal bleed before ovulation induction have negative effects on IUI outcomes in patients with polycystic ovary syndrome?

Ovarian Follicular Growth through Intermittent Vaginal Gonadotropin Administration in Diminished Ovarian Reserve Women